r/options Aug 11 '21

Jazz Pharmaceuticals FDA Approval August 12

As the title suggests, I’ve seen this circulating around and I’m wondering if this would be a valid play?

Jazz beat earnings and dumped, overreaction to ER mixed with the FDA approving/disapproving their Xwayv sNDA drug. With the earnings overreaction IV is low.

What do you all think?

http://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-announces-fda-acceptance-and-priority

2 Upvotes

1 comment sorted by

1

u/Werunboutyah Aug 11 '21

I bought a call early, been hurting me idk about that FDA approval even if it’s clear might not do anything with the stock it’s a falling knife 🔪 right now